The HemOnc Pulse Live at ASH: Tycel Phillips, MD, on the TRIANGLE Study, Frontline Therapy in MCL
By Chadi Nabhan, MD, MBA, FACP, Tycel Phillips, MD - Last Updated: January 10, 2023Tycel Phillips, MD, of the City of Hope, talks about the TRIANGLE study and frontline therapy in mantle cell lymphoma on The HemOnc Pulse, a podcast from Blood Cancers Today and the Society of Hematologic Oncology.
Advertisement
Post Tags:Lymphoma ASH 22
Advertisement
Related Posts
Machine learning may aid point-of-care clinical decision-making for NHL patients receiving CAR T-cell therapy.
Martin Dreyling, MD, discusses the TRIANGLE study and the shifting roles of autologous HSCT and chemotherapy in MCL.
Melody Smith, MD, MS, shares data on burnout in hematologist oncologists, why it occurs, and how to prevent it.
A panel moderated by Neil Love, MD, explored clinical data to assess these treatment approaches for the various types of NHL.
Clinical evaluations of this bispecific antibody as monotherapy or in polytherapy for B-cell non-Hodgkin lymphomas continue.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.